CHIME FINL INC (CHYM) — Hedge Fund Ownership Q1 2026
CHYM
- CHIME FINL INC (CHYM) is held by 4 of 84 tracked hedge funds, with Patient Capital Management (2%) and Tiger Global Management (1%) holding the largest stakes, indicating limited hedge fund interest relative to peers.
- The biggest increases in CHYM holdings came from Patient Capital Management (+42%) and Atreides Management (+8%), highlighting conviction.
- The biggest decreases in CHYM holdings came from Tiger Global Management (-22%), suggesting profit-taking or de-risking.
- Overall, hedge funds decreased exposure to CHIME FINL INC (CHYM) by -10% vs the prior quarter.
| # | Fund | % of Portfolio † | Shares † | Shares vs Prior Quarter † | Shares vs Prior Year † | Aggregate Value † | Reported Price * | Option |
|---|---|---|---|---|---|---|---|---|
| 1 |
Patient Capital Management Samantha McLemore
|
2.01% | 2.9M | +41.61% | — | $54.0M | $18.73 | — |
| 2 |
Tiger Global Management Chase Coleman
|
0.91% | 11.1M | -21.92% | — | $207.6M | $18.73 | — |
| 3 |
Atreides Management
|
0.74% | 1.6M | +7.91% | — | $30.4M | $18.73 | — |
| 4 |
Davis Selected Advisers Christopher Davis
|
0.22% | 2.5M | +2.71% | — | $47.6M | $18.73 | — |
| 4 | Total | — | 18.1M | -10.28% | — | $339.5M | — | — |
* Reported price is not an actual purchase or sale price. It is the price as of the last portfolio date.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.